Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies-Reference-Cited by-同舟云学术

Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies

Published:2024-01 Issue:1 Volume:42 Page:119-134.e12
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Goddard Erica T.,Linde Miles H.,Srivastava Shivani,Klug Grant,Shabaneh Tamer B.,Iannone Santino,Grzelak Candice A.,Marsh Sydney,Riggio Alessandra I.,Shor Ryann E.,Linde Ian L.,Guerrero Marissa,Veatch Joshua R.,Snyder Annelise G.,Welm Alana L.,Riddell Stanley R.,Ghajar Cyrus M.^ORCID

Publisher

Elsevier BV

Reference86 articles.

1. 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years;Pan;N. Engl. J. Med.,2017

2. Dormancy of mammary carcinoma after mastectomy;Karrison;J. Natl. Cancer Inst.,1999

3. The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis;Pedersen;J. Natl. Cancer Inst.,2022

4. Systemic spread is an early step in breast cancer;Hüsemann;Cancer Cell,2008

5. Quantitative evidence for early metastatic seeding in colorectal cancer;Hu;Nat. Genet.,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities;Nature Reviews Cancer;2024-09-02

2. Mismatch repair-proficient tumor footprints in the sands of immune desert: mechanistic constraints and precision platforms;Frontiers in Immunology;2024-07-19

3. ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion;Cell;2024-04

4. The senescence journey in cancer immunoediting;Molecular Cancer;2024-04-01

5. Finding the needle in the haystack;Nature Reviews Cancer;2024-02-02